Abstract
There is provided novel small molecule E3 ubiquitin ligase protein binding ligand compounds, and to their utility in PROteolysis Targeted Chimeras (PROTACs), as well as processes for their preparation thereof, and use in medicine. There is particularly provided novel small molecule E3 ubiquitin ligase protein binding inhibitorcompounds based on a fluorohydroxyproline scaffold, to their utility as ligands in synthesizing novel PROTACs, and to synthetic methods therefor.
Original language | English |
---|---|
Patent number | WO/2018/051107 |
IPC | C07D 417/12 2006.1,C07D 417/14 2006.1,C07D 495/14 2006.1,A61K 31/427 2006.1,A61K 31/551 2006.1,A61P 35/00 2006.1,A61P 29/00 2006.1 |
Priority date | 14/09/16 |
Filing date | 14/09/17 |
Publication status | Published - 22 Mar 2018 |